Objectıve: The aim of this study is to investigate the early and midterm results of valve sparing aortic root replacements. Methods: Between 1999 and 2013 a total of 7220 patients underwent cardiac operations, 26 of them (0.3%) were valve sparing aortic root replacements. The aortic pathology included either dissection or aneurysm formation. David operation was applied to all of these patients. Mean follow up period was 38AE23 months. The results of early outcome and late follow up were reviewed. Results: Mean age and Euroscore (%) of the patients were 54.1AE10 and 6.4AE1.4. Seven of the patients (26.9) were female. Mean preoperative left ventricular ejection fraction was 58.8AE7.2 %. Sixteen patients (61.5%) had additional cardiac procedure (6 coronary bypass surgery, 3 hemiarcus replacement, 1 arcus aorta replacement, 5 mitral valve repair, 1 left atrial ablation). No operative and hospital mortality was observed. Mean cross clamp time and cardiopulmonary bypass time were 114AE34 and 137AE41 minutes, mean drainage was 720AE450 ml, mean intubation time was 9.1AE3.8 hours, mean intensive care unit stay time was 28.1AE17.9 hours. During the intensive care unit stay 10 patient (38.5%) needed inotropic support. There was 3 (11.5%) intensive care unit readmission and one (%3.8) hospital readmission observed. During the late follow up there was no mortality and no need for reoperation or reintervention. Conclusıons: Our study shows valve sparing aortic root replacement is safe and feasible with low mortality and morbidity rates. Methods: We used a semiquantitative scoring system including both PE and neoplastic masses, to assess the severity of pericardial disease at diagnosis and at the last available follow-up. In a multicenter observational study we collected 333 patients (pts) with NP. We reviewed the data about 264 patients (pts) (164 males) with NP (confirmed by cytology) treated by PC or PW and CT either systemic (SCT), local (LCT) or combined SCT+LCT. The tumors were 146 lung and 29 breast carcinomas, 21 lymphomas, 32 other tumors. The outcome was classified as: Complete response (CR) if no effusion or masses were detectable at follow-up; partial response (PR) if the neoplastic score was reduced, stable disease (SD) or progression (PD) if the score was unchanged or worsened. Results: Pericardiocentesis plus LT (PC+LT) was used in 36 pts, plus SCT in 77, plus combined SCT+LT in 90; 63 pts had pericardial window plus SCT (PW+SCT). A complete or partial response was obtained in 226 pts (85%): 94% of those treated with PW+ SCT, 91% of those receiving SCT+ LCT, 85% of those treated with LT, and 73% of those receiving SCT (p<0.001). In the subgroup of lung cancer pts (n¼146), the rate of CR or PR were: 96% with combined SCT+LT, 91% with PW+SCT, 88% with PC + LT, and 64% with PC+SCT (p<0.001). In the subgroup of lung cancer, moreover, the event-free survival of pts treated with combined LCT+ SCT was significantly longer than in each of other groups of treatment (p<0.05).
Conclusıons:
The most effective treatments of neoplastic pericarditis (mostly in lung cancer) are: pericardial drainage with combined local therapy and systemic CT and pericardial window associated to systemic CT. Using systemic CT only, after pericardiocentesis the recurrence rate is 27% in all tumors, and 36% in lung cancer patients.
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Is Carotid Artery Stent Procedure an Alternative to Carotid Endarterctomy with Regional Anesthesia Using Selective Shunt Ata Niyazi Ecevit 1 , Hakki Tankut Akay 2 , Erdal Aslım 3 , Ali Harman 2 , Umut Özyer 2 , Salih Özçobano glu 3 , Bahadır Gültekin 2 , Atilla Sezgin 2 , Sait Aşlamacı 2 1 Konya Education and Research Hospital Cardiovascular Surgery Department, Konya, 2 Baskent University Hospital Cardiovascular Surgery Department, Ankara, 3 Acibadem University Hospital Cardiovascular Surgery Department, Istanbul Aim: In this study, 82 patients who were treated with carotid endarterectomy and 39 patients who were treated with stent due to carotid artery stenosis in between 2001-2009 were evaluated retrospectively and compared. Patients and Methods: Carotid artery stenting was performed by interventioanl radiology team in angiography suit. All the endarterectomy procedures were performed by the same cardiovascular sugery team. Operation times, mortality, morbidity, hospital stay times and cost analysis were calculated, recorded and compared between surgery and stent groups. Results: The number of early complications in surgery patients was 4 patients with hemorraghia (4,9%) and 10 patients in stent group (25.6%) with hemiparesia, hemiplegia, hemorraghia and disphasia. Although there was no cerebrovascular event in surgery group, in stent group 10 patients had cerebrovascular event. (P<0.001). Mortality occurred in 2 and 5 patients in surgery (2.5%) and stent (12.5%) groups respectively. The mean intensive care unit stay time in surgery and stent groups were 1.24AE1,77 and 2.5AE1,76 and hospital stay time in surgery and stent groups were 1.75AE0,88 and 3.79AE4,0 respectively. In financial analysis total costs for surgery group was 2800 Turkish liras and in stent group 3756.41 Turkish liras (P<0.001). Conclusıon: Carotid endarterectomy with regional anesthesia is a safer and cheaper treatment modality with lower rates of mortality and morbidity when compared with carotid artery stenting. Big randomized series in future studies will give more detailed information about the feasibility of these two treatment modalities.
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